Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Massachusetts
Biotech
Bayer-allied NextRNA Therapeutics winds down operations
The closure comes a year after NextRNA inked a two-program oncology pact with Bayer worth up to $547 million in upfront and milestone payments.
Darren Incorvaia
Aug 11, 2025 2:30pm
Ono Pharma lays off 83 staffers at Cambridge site
Apr 29, 2025 1:56pm
GSK to move vaccine R&D group from Maryland to Massachusetts
Feb 12, 2025 11:27am
AI firm launches US lab, welcomes new CSO and computer cluster
Jan 6, 2025 6:00am
Atlas lands $450M fund to build fresh batch of biotechs
Mar 3, 2022 9:10am
LightForce Orthodontics nets $50M for 3D-printed braces system
Nov 2, 2021 2:25pm
